Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Can Stan Polovets’ Philanthropic Vision Be a Blueprint for Future Impact Giving? Something that we wanted to talk about at ...

CEO says pharma executives discussed Trump's call to launch DTC initiatives under his Most Favored Nation policy to lower U.S. drug prices. Read more here.

While Pfizer CEO Albert Bourla, Ph.D., said he couldn’t reveal many details, he noted that Pfizer is in “very active discussions” around most favored nation drug pricing.

The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in comments on China’s rising competitiveness.

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...

A declining stock price amid steadily rising payouts means Realty Income stock offers an above-average yield of 5.5% at ...

Pfizer Q2 2025 earnings show 10% revenue growth, raised EPS guidance, strong R&D, and operational execution. Explore growth drivers and policy risks.